The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Donald Cutlip
Showing 1-13 of 13 articles
Defining device success for percutaneous coronary intervention trials: a position statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology
Chang C,
Kogame N,
Onuma Y,
Byrne R,
Capodanno D,
Windecker S,
Morel M,
Cutlip D,
Krucoff M,
Stone G,
Lansky A,
Mehran R,
Spitzer E,
Fraser A,
Baumbach A,
Serruys P
January 17, 2020 | 10.4244/EIJ-D-19-00552
Sorting out coronary stents, as time goes by
Stefanini G,
Cutlip D
December 20, 2017 | 10.4244/EIJV13I11A198
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document
Kappetein A,
Head S,
Généreux P,
Piazza N,
Van Mieghem NM,
Blackstone E,
Brott T,
Cohen D,
Cutlip D,
Van Es G-A,
Hahn R,
Kirtane A,
Krucoff M,
Kodali S,
Mack M,
Mehran R,
Rodés-Cabau J,
Vranckx P,
Webb JG,
Windecker S,
Serruys P,
Leon M
November 20, 2012 | 10.4244/EIJV8I7A121
Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation
De Luca G,
Gibson CM,
Huber K,
Dudek D,
Cutlip D,
Zeymer U,
Gyöngyösi M,
Bellandi F,
Noc M,
Arntz H-R,
Maioli M,
Secco G,
Zorman S,
Gabriel H,
Emre A,
Rakowski T,
van't Hof A
August 24, 2012 | 10.4244/EIJV8I4A74
Clinical event committees in coronary stent trials: insights and recommendations based on experience in an unselected study population
Vranckx P,
McFadden E,
Mehran R,
Cutlip D
July 27, 2012 | 10.4244/EIJV8I3A56
Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity
Vranckx P,
Cutlip D,
Mehran R,
Kint P-P,
Silber S,
Windecker S,
Serruys P
February 25, 2010
Long-term clinical outcomes with the next-generation Resolute Stent System: a report of the two-year follow-up from the RESOLUTE clinical trial
Meredith I,
Worthley S,
Whitbourn R,
Walters D,
McClean D,
Ormiston J,
Horrigan M,
Wilkins G,
Hendriks R,
Matsis P,
Muller D,
Cutlip D
January 15, 2010
Clinical endpoints in transcatheter aortic valve implantation: a call to ARC for standardised definitions
Piazza N,
Cutlip D,
Onuma Y,
Kappetein A,
de Jaegere P,
Serruys P
May 19, 2009
Identifying stent thrombosis, a critical appraisal of the Academic Research Consortium (ARC) consensus definitions: a lighthouse and as a toe in the water
Vranckx P,
Kint P-P,
Morel M,
Van Es G-A,
Serruys P,
Cutlip D
August 20, 2008
An introduction to "A critical appraisal of the safety concerns tempering the success of drug-eluting stents"
Daemen J,
Cutlip D,
Windecker S
August 20, 2008
The next-generation Endeavor™ Resolute™ stent: 4-month clinical and angiographic results from the Endeavor™ Resolute™ first-in-man trial
Meredith I,
Worthley S,
Whitbourn R,
Walters D,
Popma J,
Cutlip D,
Fitzgerald P
May 22, 2007
Comparison of the CardioShield filter with the guardwire balloon in the prevention of embolisation during vein graft intervention: results from the CAPTIVE randomised trial
Holmes D,
Coolong A,
O’ Shaughnessy C,
Chauhan M,
van Langenhove G,
Hall P,
Vermeersch P,
Verlee P,
Popma J,
Cutlip D,
Kuntz R
August 20, 2006
First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novonative coronary artery lesions: Endeavor I Trial
Meredith I,
Ormiston J,
Whitbourn R,
Kay IP,
Muller D,
Bonan R,
Popma J,
Cutlip D,
Fitzgerald P,
Prpic R,
Kuntz R
August 20, 2005
1
Latest news
AHEAD OF PRINT
Single antiplatelet therapy directly after PCI
FREE ARTICLE - Niels M.R. van der Sangen et al
February 3, 2023
AHEAD OF PRINT
Physiological changes post-CTO PCI and predictors
FREE ARTICLE - Sarosh A Khan et al
February 1, 2023
AHEAD OF PRINT
In-stent neoatherosclerosis in LEAD
FREE ARTICLE - Arne Müller et al
January 30, 2023
NEW ISSUE
M-TEER State-of-the-Art; Comparing ACURATE Neo2 to Evolut PRO/PRO + and the SAPIEN 3 Ultra; Mini Focus on Vulnerable Plaque: Plaque Composition and Vulnerability – Radial Wall Strain...
January 23, 2023
AHEAD OF PRINT
Cerebral embolic protection in TAVI
FREE ARTICLE - Rajesh K. Kharbanda et al
January 26, 2023
AHEAD OF PRINT
First experience of LAAO using a 3D mini TOE probe with conscious sedation
FREE ARTICLE - Laura Sanchis et al
January 25, 2023
AHEAD OF PRINT
“Lotus root”: a novel OCT imaging pattern in spontaneous coronary artery dissection
FREE ARTICLE - David del Val et al
January 20, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke